STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
Reported by STAT News · all stories from statnews.com
Editorial digest
The leader of the FDA's digital health division has announced that regulatory guidance for generative artificial intelligence tools is forthcoming. This will clarify how the agency plans to oversee this rapidly advancing technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom9/14/2026
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
A specific financial figure illuminates Republican health policy and the rise of GLP-1 prescriptions.
- Trusted health newsroom9/14/2026
The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
Hospital leaders report a federal rural healthcare initiative is falling short of expectations.
- Trusted health newsroom9/9/2026
STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
ARPA-H plans to invest $62 million in FDA-authorized AI for heart failure treatment.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.